Private Equity 3 Days

Last updated: June 17, 2026, 2:30 AM ET

Deal Activity Across Verticals

Rubicon backs case‑management software provider with an undisclosed minority stake, expanding its footprint in the nonprofit‑tech niche, while Space Age Electronics adds fire‑safety maker SprinkGuard to broaden its product line for life‑safety systems. In the retail services space, H.I.G. Capital exits Bluebird through a founder‑led recapitalisation that returns capital to the firm and signals confidence in the agency’s ecommerce optimisation platform. Meanwhile, GreenArrow acquires electrical contractor HBC Company to deepen its transportation‑infrastructure services portfolio, and CVC takes a majority stake in prosthetic maker WillowWood to bolster its health‑technology exposure. These transactions illustrate private equity’s continued push into niche software, safety equipment and specialized health devices as investors chase higher‑margin, defensible businesses.

Technology‑Focused Acquisitions

Francisco Partners purchases network‑security firm EfficientIP for an undisclosed sum, adding DNS, DHCP and IP‑address‑management capabilities to its cyber‑infrastructure suite. At the same time, Flatirons snaps up enterprise‑AI platform Scope AR, giving the Boulder‑based sponsor a foothold in augmented‑reality tools for aerospace and defence maintenance. The trend extends to data‑center supply chains, where Lead Edge Capital acquires electric‑components platform Elektrik to capture procurement spend from the expanding hyperscale market. Together, these deals underscore a private‑equity tilt toward software and hardware that support the rapid digitisation of enterprise operations.

Consumer and Food‑Service Deals

LongRange Capital agrees to buy Pizza Hut for $1.5bn, excluding the China franchise, marking one of the largest recent takings‑private of a legacy restaurant brand and reflecting confidence in the chain’s cash‑flow recovery post‑pandemic. In the dairy sector, Hoffmann Family of Companies purchases Cedar Crest Ice Cream, adding a regional brand to its portfolio and leveraging synergies with Oberweis Dairy, already under its umbrella. Parallel to these moves, Gemspring‑backed Residence acquires influencer‑marketing agency GateMaker, signalling private‑equity interest in the creator‑economy as brands seek direct consumer engagement channels.

Financial Services and Credit Structuring

Blackstone‑owned Ancestry lines up a $2.25bn loan to refinance existing debt, highlighting the genealogy firm’s need for liquidity as it pursues growth initiatives. In Europe, EQT’s Intertek take‑private draws £5bn in bank financing proposals, with multiple lenders competing to fund the potential delisting of the product‑testing group, a clear sign of strong appetite for leveraged buyouts in the mid‑market. Likewise, L Catterton‑backed Birkenstock prepares a €900 m bond to fund shareholder buybacks, demonstrating how sponsor‑owned consumer brands are turning to capital markets to optimise balance sheets.

Secondary Market and Fundraising Activity

Argosy doubles fund size with a $145 m raise, targeting small‑deal secondaries and expanding its capacity to write checks from $100 k to $10 m. Across the Atlantic, CalPERS appoints a new alts head to oversee a $250bn portfolio, with a mandate that includes private‑credit and secondary investments, reinforcing the pension fund’s shift toward alternative assets. In the credit arena, Blue Owl leads Veld Capital’s €355 m credit CV, providing follow‑on capital to sustain a robust pipeline of opportunistic debt deals.

Strategic Exits and Portfolio Optimisation

Morgan Stanley exits Brazos Delaware II for $1.6bn, achieving an 8× EBITDA multiple and exemplifying the firm’s strategy to monetise legacy fund assets at premium valuations. Similarly, Abry closes a $780 m continuation fund for Centauri Health Solutions, allowing the sponsor to retain a high‑performing healthcare asset while offering liquidity to existing investors. In the biotech space, H.I.G. Capital sells CRO Celerion to THL Partners for $1.8bn, delivering a sizable return on a long‑held clinical‑research platform and freeing capital for new opportunities.

Emerging‑Market and Sector‑Specific Plays

Inflexion invests in Ranger Fire and Security, partnering with Hyperion Equity to expand the firm’s fire‑protection and security offerings across the UK, while Inflexion also backs a majority stake in the same company after a parallel strategic review. In the European defence tech arena, UK defence prime BAE Systems invests €50 m in VCs Lakestar and Expeditions, seeding startups that could accelerate AI‑driven capabilities for national security. Meanwhile, Cathay Capital acquires a majority stake in product‑data SaaS firm Equadis, tapping a customer base of over 600 global consumer‑goods giants and reinforcing the sponsor’s focus on data‑intensive supply‑chain solutions.

Health‑Tech and Life‑Sciences Growth

Cleargate Capital backs health‑tech firm Fellow Health Partners, supporting a platform that serves more than 500 clinicians across 50 organisations, reflecting private‑equity confidence in digital health workflow tools. Renovus‑backed xFact adds govtech firm Stonewall, extending its public‑sector digital‑transformation capabilities, while Prime Radiant makes its first investment with a $50 m stake in Cellares, highlighting a new advisory firm’s commitment to early‑stage life‑science ventures. These moves illustrate a broader trend of capital flowing into technology that enhances clinical efficiency and public‑sector service delivery.

Strategic Realignments and Corporate Governance

John Redett says Carlyle is “better than ever” after a US overhaul, suggesting that the firm’s restructuring is bearing fruit and may spur further fundraising. In a parallel development, Jardine pivots to a private‑equity model with a $500 m buyback and asset sales, converting a historic conglomerate into an active investor and potentially reshaping its capital allocation. Finally, Elliott builds a near‑5% stake in Bunzl and urges buybacks, indicating activist pressure on a diversified distribution group to unlock shareholder value through capital returns and possible strategic reviews.